Abstract
Investigations in both healthy and clinical populations support the effectiveness of cognitive-behavioral interventions for immune enhancement and symptom reduction. However, there is a paucity of research examining these interventions in human immunodeficiency virus (HIV) positive populations, and existing studies lack precision in design. In this study, HIV seropositive subjects, blocked by illness stage, were randomized to a guided imagery (N=23) or progressive muscle relaxation (PMR) (N=22) treatment, or a control group (N = 24). The six-week treatments were delivered via audiotape following brief face-to-face instruction, and effects on fatigue, depression, and three measures of cellular immunity were examined. Pre and posttreatment measures included the Center for Epidemiologic Studies Depression Scale (CES-D), Sleep and Rest subscale of the Sickness Impact Profile (SIP), CD4+ and CD16+ lymphocyte numbers, and CD4+:CD8 + T lymphocyte ratio. Data were analyzed using a hierarchical multiple regression model, holding pretreatment effects constant while assessing the contribution of each treatment to the dependent variables. The guided imagery group had a significant decrease in depression and fatigue, while the PMR group demonstrated an increased CD4+ T lymphocyte count and a reduction in depression. Findings supported the effectiveness of both interventions for symptom alleviation, and of PMR for immune enhancement in persons with HIV, and suggest a differential effect for the two treatments in this population.
Similar content being viewed by others
References
Centers for Disease Control: Pneumocystis pneumonia-Los Angeles.Morbidity and Mortality Weekly Report. 1981,30:250–252.
Centers for Disease Control: The HIV/AIDS epidemic: The first 10 years.Morbidity and Mortality Weekly Report. 1991,40:357–369.
Collier AC, Bozzette S, Coombs RW, et al: A pilot study of low-dose zidovudine in human immunodeficiency virus infection.New England Journal of Medicine. 1990,525:1015–1021.
Kaslow RA, Phair JP, Freidman HB, et al: Infection with the human immunodeficiency virus: Clinical manifestations and their relationship to immune deficiency.Annals of Internal Medicine. 1987,107:474–480.
Graham NMH, Zeger SL, Park LP, et al: The effects of early treatment of human immunodeficiency virus infection.New England Journal of Medicine. 1992,526:1037–1042.
Clement M, Hollander H: Natural history and management of the seropositive patient. In Sande MA, Volberding PA (eds),The Medical Management of AIDS. Philadelphia, PA: Saunders, 1992, 87–96.
Fox R, Eldred LJ, Fuchs EJ, et al: Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men.AIDS. 1987,1:35–38.
Flaskerud JH, Ungvarski PJ:HIV/AIDS: A Guide to Nursing Care. Philadelphia, PA: W. B. Saunders, 1992.
National Center for Nursing Research:HIV Infection: Prevention and Care. Bethesda, MD: U.S. Department of Health and Human Services, 1990.
National Institute of Allergy and Infectious Diseases:HIV/AIDS Research Agenda: Executive Summary. Washington, DC: National Institutes of Health, 1993.
Cunningham AJ: Mind, body, and immune response. In Ader R (ed),Psychoneuroimmunology. San Diego, CA: Academic Press, 1981, 609–617.
Pert C, Ruff MR, Weber RJ, et al: Neuropeptides and their receptors: A psychosomatic network.The Journal of Immunology. 1985,135:820s-826s.
Wybran J, Schandene L, Van Vooren JP, et al: Immunologic properties of methionine-enkephalin, and therapeutic implications in AIDS, ARC, and cancer.Annals of the New York Academy of Sciences. 1987,496:108–114.
Plotnikoff NP, Miller GC, Nimeh N, et al: Enkephalins and T-cell enhancement in normal volunteers and cancer patients.Annals of the New York Academy of Sciences. 1987,496:608–619.
Teshima H, Sogawa H, Mizobe K, et al: Application of psychoim-munotherapy in patients with alopecia universalis.Psychotherapy and Psychosomatics. 1991,56:235–241.
Levy JA: Viral and immunologic factors in HIV infection. In Sande MA, Volberding PA (eds),The Medical Management of AIDS. Philadelphia, PA: Saunders, 1992, 18–32.
Roitt I, Brostoff J, Male D:Immunology. St. Louis, MO: Mosby, 1994.
Stites DP, Terr AI, Parslow TG:Basic and Clinical Immunology. Norwalk, CT: Appleton Lange, 1994.
Saag MS: AIDS testing: Now and in the future. In Sande MA, Volberding PA (eds),The Medical Management of AIDS. Philadelphia, PA: Saunders, 1992, 33–53.
Gerstoff J, Dickmeiss E, Mathieson L: Cytotoxic capabilities of lymphocytes from patients with the acquired immunodeficiency syndrome.Scandinavian Journal of Immunology. 1985,22:463–470.
(21)Ticchioni M, Sapir J, Pugliese P, et al: Natural killer cells at different clinical stages of human immunodeficiency virus infection: A one-year prospective study of 163 patients.The Ninth International Conference on AIDS, (Abstract No. PO-A24-0552). Berlin, Germany: 1993.
Cai Q, Huang X, Rappocciolo G, et al: Natural killer cell responses in homosexual men with early HIV infection.Journal of Acquired Immune Deficiency Syndromes. 1990,5:669–676.
Longo MB, Spross JA, Locke AM: Identifying major concerns of persons with AIDS.Clinical Nurse Specialist. 1990,4:21–26.
Nyamathi AM, Hedderman M: Community issues. In Flaskerud JH (ed),AIDS/HIV Infection. Philadelphia, PA: Saunders, 1989, 198–214.
Perry SW, Tross S: Psychiatric problems of AIDS in-patients at the New York Hospital: A preliminary report.Public Health Reports. 1984,99:200–205.
Rodin G, Craven J, Littlefleld C:Depression in the Medically Ill. New York: Brunner/Mazel, 1991.
Tross S, Hirsch DA: Psychological distress and neuropsychological complications of HIV infection and AIDS.American Psychologist. 1988,43:929–934.
(28)Williams C, Lubeck DP: HIV related fatigue.The Ninth International Conference on AIDS, (Abstract No. PO-B01-0885). Berlin, Germany: 1993.
Darko DF, McCutchan JA, Kripke DF, et al: Fatigue, sleep disturbance, disability, and indices of progression of HIV infection.American Journal of Psychiatry. 1992,149:514–520.
(30)Doob PR, MacFadden DK: The impact of peptide T on HIV-related fatigue and health-related quality-of-life.The Eighth International Conference on AIDS, (Abstract No. PuB 7149). Amsterdam: 1992.
(31)Burack JH, Stall RD, Barrett DC, et al: Depression predicts accelerated CD4 decline among gay men in San Francisco.The Eighth International Conference on AIDS, (Abstract No. WeC 1031). Amsterdam: 1992.
Lyketsos CG, Hoover DR, Guccione M, et al: Depressive symptoms as predictors of medical outcomes in HIV.Journal of the American Medical Association. 1993,270:2563–2567.
Herbert TB, Cohen S: Depression and immunity: A meta-analytic review.Psychological Bulletin. 1993,113:472–486.
Kemeny ME, Weiner H, Taylor SE, et al: Repeated bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men.Health Psychology. 1994,13:14–24.
Solomon GF, Kemeny MF, Temoshok L: Psychoneuroimmuno-logic aspects of human immunodeficiency virus infection. In Ader R, Felten DL, Cohen N (eds),Psychoneuroimmunology. New York: Academic Press, 1991, 1081–1113.
(36)Temoshok L, Sweet DM, Moulton JM, et al: A longitudinal study of distress and coping in men with AIDS and AIDS related complex.The Third International Conference on AIDS, (Abstract No. WP. 201). Washington, DC: 1987.
Ostrow DG, Monjan A, Joseph J, et al: HIV-related symptoms and psychological functioning in a cohort of homosexual men.American Journal of Psychiatry. 1989,146:737–742.
Rabkin JG, Williams JB, Remien RH, et al: Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men.Archives of General Psychiatry. 1991,48:111–119.
Kelly JA, Murphy DA: Psychological interventions with AIDS and HIV: Prevention and treatment.Journal of Consulting and Clinical Psychology. 1992,60:576–585.
Miller D, Riccio M: Non-organic and psychosocial syndromes associated with HIV-1 infection and disease.AIDS. 1990,4:381–388.
Black S, Humphrey JH, Niven JS: Inhibition of immediate-type hypersensitivity response by direct suggestion under hypnosis.British Medical Journal. 1963,1:925–929.
Zacharaiae R, Bjerring P, Arendt-Nielsen L: Modulation of Type I immediate and Type IV delayed immunoreactivity using direct suggestion and guided imagery during hypnosis.Allergy. 1989,44: 537–542.
Rider MS, Achterberg J: Effect of music-assisted imagery on neutrophils and lymphocytes.Biofeedback and Self-Regulation. 1989,14:247–257.
Zachariae R, Kristensen JS, Hokland P, et al: Effect of psychological intervention in the form of relaxation and guided imagery on cellular immune function in normal healthy subjects.Psychotherapy and Psychosomatics. 1990,54:32–39.
Hall HR, Minnes L, Tosi M, et al: Voluntary modulation of neutrophil adhesiveness using a cyberphysiologic strategy.International Journal of Neuroscience. 1992,63:287–297.
Jasnoski ML, Kugler J: Relaxation, imagery, and neuroimmuno-modulation.Annals of the New York Academy of Sciences. 1987,496:722–730.
Olness K, Culbert T, Uden D: Self-regulation of salivary immunoglobulin A by children.Pediatrics. 1989,83:66–71.
Antoni MH, Baggett L, August S, et al: Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity.Journal of Clinical and Consulting Psychology. 1991,59:906–915.
(49)Coates SJ, McKusick L: The efficacy of stress management in reducing high risk behavior and improving immune function in HIV antibody positive men.The Third International Conference on AIDS, (Abstract No. WP. 232). Washington, DC: 1987.
Auerbach JE, Oleson TD, Solomon GF: Biofeedback, guided imagery, and hypnosis as an adjunctive treatment for AIDS and AIDS-related complex.Proceedings of the Third National Conference on the Psychology of Health, Immunity, and Disease. Storrs, CT: The National Institute for the Clinical Application of Behavioral Medicine, 1992, 50.
Coates TJ, McKusick L, Kuno R, et al: Stress reduction training changed number of sexual partners but not immune function in men with HIV.American Journal of Public Health. 1989,79:885–886.
(52)Karasic D, Targ E, Diefenbach P, et al: Structured group therapy and fluoxetine as treatment for mood disorder in HIV-seropositive individuals.The Eighth International Conference on AIDS, (Abstract No. PuB 7272). Amsterdam: 1992.
Bohachick P: Progressive relaxation training in cardiac rehabilitation: Effect on psychologic variables.Nursing Research. 1984,33:283–287.
Jarvinien PJ, Gold SR: Imagery as an aid in reducing depression.Journal of Clinical Psychology. 1981,57:523–529.
Leja AM: Using guided imagery to combat postsurgical depression.Journal of Gerontological Nursing. 1989,15:6–11.
Fawzy FI, Namir S, Wolcott DL: Structured group intervention model for AIDS patients.Psychiatric Medicine. 1989,7:35–45.
(57)Mulder CL, Emmelkamp PM, Antoni MH, et al: Immunological and psychological effects of a cognitive behavioral vs. an experiential group therapy program for asymptomatic HIV seropositive homosexual men.The Eighth International Conference on AIDS, (Abstract No. PoB 3809). Amsterdam: 1992.
Perry SW, Fishman B, Jacobsberg L, Young J, Frances A: Effectiveness of psychoeducational interventions in reducing emotional distress after human immunodeficiency virus antibody testing.Archives of General Psychiatry. 1991,48:143–147.
Centers for Disease Control: Human immunodeficiency virus (HIV) infection codes and new codes for Kaposi’s sarcoma.Mortality and Morbidity Weekly Report. 1991,40(RR-9):1–9.
Kiecolt-Glaser JK: Methodological issues in behavioral immunology research with humans.Brain, Behavior and Immunity. 1987,2:67–78.
Taylor JMG, Fahey JL, Detels R, et al: CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use.Journal of Acquired Immune Deficiency Syndromes. 1989,2:114–124.
Bergner M, Bobbin RA, Carter WB, et al: The Sickness Impact Profile.Medical Care. 1981,79:787–805.
Barofsky I, Legro MW: Definition and measurement of fatigue.Review of Infectious Diseases. 1991,75(Suppl. 1):S94-S97.
Radloff LS: The CES-D scale.Applied Psychological Measurement. 1977,1:385–401.
Lipsey MW: Design Sensitivity.Newbury Park, CA: Sage, 1990.
Cohen J:Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977.
Kiecolt-Glaser JK, Glaser R: Stress and immune function. In Ader R, Felten DL, Cohen N (eds),Psychoneuroimmunology. New York: Academic Press, 1991, 849–867.
(68)Eller LS: Effects of cognitive-behavioral interventions: Health-related quality-of-life and cellular immunity in persons with HIV.Psychoneuroimmunology Research Society, Research Perspectives in Psychoneuroimmunology, (Abstract No. A43). Key Biscayne, FL: November 16–20, 1994.
Author information
Authors and Affiliations
Additional information
Preparation of this manuscript was supported in part by a grant from University Hospitals of Cleveland, Cleveland, OH, and a postdoctoral fellowship to the author from the National Institute of Nursing Research (No. T32 NR07052, Janice M. Zeller, R.N., Ph.D., Project Director).
About this article
Cite this article
Lucille Sanzero Eller, R.N. Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV. ann. behav. med. 17, 339–348 (1995). https://doi.org/10.1007/BF02888599
Issue Date:
DOI: https://doi.org/10.1007/BF02888599